Atlas FDA

SOLESTA

FDA premarket approval P100014/S005 · decided 2012-04-24

Approval details

PMA number
P100014
Supplement
S005
Supplement type
Normal 180 Day Track No User Fee
Supplement reason
Postapproval Study Protocol - OSB
Trade name
SOLESTA
Generic name
AGENT, BULKING, INJECTABLE FOR GASTRO-UROLOGY USE
Applicant
Palette Life Sciences
Date received
2012-03-20
Decision date
2012-04-24
Days to decision
35 days
Decision code
APPR
Product code
LNM
Advisory committee
Gastroenterology, Urology
Expedited review
No
Location
Santa Barbara, CA
Statement
APPROVAL OF THE POST-APPROVAL STUDY PROTOCOL.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
Barrigel Injectable Gel (K220641)Palette Life Sciences2022-05-26